276 related articles for article (PubMed ID: 25587030)
1. Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion.
Leontieva OV; Blagosklonny MV
Oncotarget; 2014 Dec; 5(24):12715-27. PubMed ID: 25587030
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin, proliferation and geroconversion to senescence.
Blagosklonny MV
Cell Cycle; 2018; 17(24):2655-2665. PubMed ID: 30541374
[TBL] [Abstract][Full Text] [Related]
3. Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).
Leontieva OV; Demidenko ZN; Blagosklonny MV
Oncotarget; 2015 Sep; 6(27):23238-48. PubMed ID: 26177051
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia suppresses conversion from proliferative arrest to cellular senescence.
Leontieva OV; Natarajan V; Demidenko ZN; Burdelya LG; Gudkov AV; Blagosklonny MV
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13314-8. PubMed ID: 22847439
[TBL] [Abstract][Full Text] [Related]
5. MEK drives cyclin D1 hyperelevation during geroconversion.
Leontieva OV; Demidenko ZN; Blagosklonny MV
Cell Death Differ; 2013 Sep; 20(9):1241-9. PubMed ID: 23852369
[TBL] [Abstract][Full Text] [Related]
6. S6K in geroconversion.
Leontieva OV; Demidenko ZN; Blagosklonny MV
Cell Cycle; 2013 Oct; 12(20):3249-52. PubMed ID: 24036549
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging.
Blagosklonny MV
Aging (Albany NY); 2012 Mar; 4(3):159-65. PubMed ID: 22394614
[TBL] [Abstract][Full Text] [Related]
8. Geroconversion: irreversible step to cellular senescence.
Blagosklonny MV
Cell Cycle; 2014; 13(23):3628-35. PubMed ID: 25483060
[TBL] [Abstract][Full Text] [Related]
9. CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion.
Leontieva OV; Blagosklonny MV
Cell Cycle; 2013 Sep; 12(18):3063-9. PubMed ID: 23974099
[TBL] [Abstract][Full Text] [Related]
10. Gerosuppression in confluent cells.
Leontieva OV; Blagosklonny MV
Aging (Albany NY); 2014 Dec; 6(12):1010-8. PubMed ID: 25585637
[TBL] [Abstract][Full Text] [Related]
11. Suppression of replicative senescence by rapamycin in rodent embryonic cells.
Pospelova TV; Leontieva OV; Bykova TV; Zubova SG; Pospelov VA; Blagosklonny MV
Cell Cycle; 2012 Jun; 11(12):2402-7. PubMed ID: 22672902
[TBL] [Abstract][Full Text] [Related]
12. TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.
Han J; Kim S; Yang JH; Nam SJ; Lee JE
Oncol Rep; 2012 Feb; 27(2):517-22. PubMed ID: 22020547
[TBL] [Abstract][Full Text] [Related]
13. Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program.
Leontieva OV; Demidenko ZN; Blagosklonny MV
Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8832-7. PubMed ID: 24889617
[TBL] [Abstract][Full Text] [Related]
14. Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta.
Martin PM; Aeder SE; Chrestensen CA; Sturgill TW; Hussaini IM
Oncogene; 2007 Jan; 26(3):407-14. PubMed ID: 16832347
[TBL] [Abstract][Full Text] [Related]
15. Phorbol 12-myristate 13-acetate inhibits FRO anaplastic human thyroid cancer cell proliferation by inducing cell cycle arrest in G1/S phase: evidence for an effect mediated by PKCdelta.
Afrasiabi E; Ahlgren J; Bergelin N; Törnquist K
Mol Cell Endocrinol; 2008 Sep; 292(1-2):26-35. PubMed ID: 18541361
[TBL] [Abstract][Full Text] [Related]
16. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
17. Elimination of proliferating cells unmasks the shift from senescence to quiescence caused by rapamycin.
Leontieva OV; Demidenko ZN; Gudkov AV; Blagosklonny MV
PLoS One; 2011; 6(10):e26126. PubMed ID: 22022534
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin-induced G1 cell cycle arrest employs both TGF-β and Rb pathways.
Chatterjee A; Mukhopadhyay S; Tung K; Patel D; Foster DA
Cancer Lett; 2015 May; 360(2):134-40. PubMed ID: 25659819
[TBL] [Abstract][Full Text] [Related]
19. Cellular senescence: when growth stimulation meets cell cycle arrest.
Blagosklonny MV
Aging (Albany NY); 2023 Feb; 15(4):905-913. PubMed ID: 36805938
[TBL] [Abstract][Full Text] [Related]
20. Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB.
Varma S; Khandelwal RL
Biochim Biophys Acta; 2007 Jan; 1770(1):71-8. PubMed ID: 16952420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
